{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:15:50Z","timestamp":1793740550792,"version":"4.6.1"},"reference-count":189,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031639","name":"Kidney Disease: Improving Global Outcomes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016730","name":"Torii Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.kint.2024.11.013","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T23:19:59Z","timestamp":1737674399000},"page":"405-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":201,"title":["Chronic kidney disease\u2013mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference"],"prefix":"10.1016","volume":"107","author":[{"given":"Markus","family":"Ketteler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-4321","authenticated-orcid":false,"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0881-2615","authenticated-orcid":false,"given":"Hanne Skou","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Komaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Nickolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smeeta","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4607-9415","authenticated-orcid":false,"given":"Marc G.","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-2831","authenticated-orcid":false,"given":"Michael","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7369-7812","authenticated-orcid":false,"given":"Michel","family":"Jadoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7902-2127","authenticated-orcid":false,"given":"Rosa M.A.","family":"Moys\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ashuntantang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Bavanandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bellasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Bueno de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bushinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Bressendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eug\u00eania","family":"Fernandes Canziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluizio Barbosa","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cejka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Denburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grahame J.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosilene M.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fusaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bak-Leong","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Alberto","family":"Gomez Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando M.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Haarhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Huish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Khairallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young joo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Lafage-Proust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Loughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Mac-Way","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando Luis","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar U.","family":"Nigwekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene L.","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Perwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia J.","family":"Scialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paweena","family":"Susantitaphong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Tchokhonelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Terano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Yee-Moon Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wesseling-Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"113","key":"10.1016\/j.kint.2024.11.013_bib1","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2024.11.013_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2024.11.013_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251035","article-title":"Low bone density, vertebral fracture and FRAX score in kidney transplant recipients: a cross-sectional cohort study","volume":"16","author":"Velioglu","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2024.11.013_bib4","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib5","article-title":"Contemporary kidney transplantation has a limited impact on bone microarchitecture","volume":"16","author":"Meng","year":"2022","journal-title":"Bone Rep"},{"key":"10.1016\/j.kint.2024.11.013_bib6","article-title":"Mineral and bone disorder after kidney transplantation: a single-center cohort study","volume":"45","author":"Sun","year":"2023","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2024.11.013_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261686","article-title":"Bone volume, mineral density, and fracture risk after kidney transplantation","volume":"17","author":"Keronen","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2024.11.013_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ndt\/gfad190","article-title":"Serum phosphate is associated with increased risk of bone fragility fractures in hemodialysis patients","volume":"39","author":"Barrera-Baena","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2224456","article-title":"Incidence of bone fractures among patients on maintenance hemodialysis","volume":"45","author":"Kashgary","year":"2023","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2024.11.013_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00774-019-01041-9","article-title":"Bone fracture risk factors in prevalent hemodialysis patients","volume":"38","author":"Matias","year":"2020","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.kint.2024.11.013_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib12","article-title":"Relationship between fetuin A, vascular calcification and fracture risk in dialysis patients","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2024.11.013_bib13","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00198-019-05033-3","article-title":"Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease","volume":"30","author":"Geng","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2024.11.013_bib14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A\u00a0higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib16","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2024.11.013_bib17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib19","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1016\/j.transproceed.2019.03.071","article-title":"Pretransplant osteoporosis and osteopenia are risk factors for fractures after kidney transplantation","volume":"51","author":"Lee","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2024.11.013_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s10157-022-02210-3","article-title":"Lateral spine dual-energy X-ray absorptiometry and the risk of fragility fractures in long-term kidney graft recipients","volume":"26","author":"Hori","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib21","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2024.11.013_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European consensus statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib24","first-page":"1595","article-title":"The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients","volume":"52","author":"Fusaro","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.kint.2024.11.013_bib25","first-page":"e20230119","article-title":"Renal osteodystrophy and clinical outcomes: a prospective cohort study","volume":"46","author":"Carbonara","year":"2024","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.kint.2024.11.013_bib26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.kint.2021.04.043","article-title":"Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment","volume":"100","author":"Haarhaus","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib27","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/ndt\/gfab239","article-title":"Patterns of renal osteodystrophy 1 year after kidney transplantation","volume":"36","author":"J\u00f8rgensen","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2215\/CJN.0000000000000434","article-title":"Effects of vitamin D3 supplementation on incident fractures by eGFR in VITAL","volume":"19","author":"Hsu","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D supplements and prevention of cancer and cardiovascular disease","volume":"380","author":"Manson","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.11.013_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jbmr.4469","article-title":"Cholecalciferol supplementation attenuates bone loss in incident kidney transplant recipients: a prespecified secondary endpoint analysis of a randomized controlled trial","volume":"37","author":"Tsujita","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2024.11.013_bib31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajt.2022.12.007","article-title":"Nonskeletal and skeletal effects of high doses versus low doses of vitamin D(3) in renal transplant recipients: results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial","volume":"23","author":"Courbebaisse","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ndt\/gfab184","article-title":"Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort","volume":"37","author":"Bozic","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","article-title":"Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP)","volume":"53","author":"Bhuriya","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ndt\/gfaa195","article-title":"The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation","volume":"36","author":"Tabibzadeh","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib35","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib37","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","article-title":"Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America: the CORES study","volume":"26","author":"Naves-D\u00edaz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ekir.2024.01.002","article-title":"Alkaline phosphatase and parathyroid hormone levels: international variation and associations with clinical outcomes in the DOPPS","volume":"9","author":"Yamamoto","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.11.013_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12882-018-1056-5","article-title":"Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Yamamoto","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib40","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib41","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12882-022-02993-3","article-title":"Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients","volume":"23","author":"Germain","year":"2022","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jsbmb.2014.11.022","article-title":"Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation","volume":"148","author":"Petkovich","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.kint.2024.11.013_bib44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000529523","article-title":"Evaluation of therapies for secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease","volume":"9","author":"Strugnell","year":"2023","journal-title":"Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib45","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1210\/clinem\/dgad289","article-title":"Paricalcitol and extended-release calcifediol for treatment of secondary hyperparathyroidism in non-dialysis chronic kidney disease: results from a network meta-analysis","volume":"108","author":"Franchi","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2024.11.013_bib46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.kint.2018.05.013","article-title":"Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"94","author":"Fukagawa","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib47","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.0000000000000253","article-title":"Efficacy and safety of upacicalcet in hemodialysis patients with secondary hyperparathyroidism: a randomized placebo-controlled trial","volume":"18","author":"Shigematsu","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib48","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1001\/jama.2018.17749","article-title":"Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism receiving maintenance hemodialysis: the J-DAVID randomized clinical trial","volume":"320","author":"Shoji","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2024.11.013_bib49","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/ndt\/gfad043","article-title":"Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial","volume":"38","author":"Wang","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.ajkd.2023.10.007","article-title":"Impact of parathyroidectomy versus oral cinacalcet on bone mineral density in patients on peritoneal dialysis with advanced secondary hyperparathyroidism: the PROCEED pilot randomized trial","volume":"83","author":"Wang","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib51","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1210\/clinem\/dgac142","article-title":"Parathyroidectomy vs cinacalcet among patients undergoing hemodialysis","volume":"107","author":"Komaba","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2024.11.013_bib52","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.12911","article-title":"A\u00a0randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism","volume":"14","author":"Evenepoel","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib53","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2015060622","article-title":"A\u00a0randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism","volume":"27","author":"Cruzado","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MNH.0000000000000840","article-title":"Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach","volume":"32","author":"Disthabanchong","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2024.11.013_bib55","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jbmr.4563","article-title":"Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease","volume":"37","author":"Miller","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2024.11.013_bib56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00774-022-01332-8","article-title":"Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease","volume":"40","author":"Miyauchi","year":"2022","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.kint.2024.11.013_bib57","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1080\/03007995.2019.1656955","article-title":"Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial","volume":"35","author":"Bilezikian","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.kint.2024.11.013_bib58","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jbmr.3676","article-title":"Effects of denosumab and alendronate on bone health and vascular function in hemodialysis patients: a randomized, controlled trial","volume":"34","author":"Iseri","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2024.11.013_bib59","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","article-title":"Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study","volume":"39","author":"Sato","year":"2021","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.kint.2024.11.013_bib60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00223-022-01031-6","article-title":"One-year romosozumab treatment followed by one-year denosumab treatment for osteoporosis in patients on hemodialysis: an observational study","volume":"112","author":"Saito","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.kint.2024.11.013_bib61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5414\/CN110993","article-title":"Treatment of bone loss in CKD5D: better survival in patients with non-high bone turnover","volume":"98","author":"Malluche","year":"2022","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib62","first-page":"1195","article-title":"Long-term effect of denosumab on bone disease in patients with CKD","volume":"18","author":"Iseri","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2023.28239","article-title":"Severe hypocalcemia with denosumab among older female dialysis-dependent patients","volume":"331","author":"Bird","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2024.11.013_bib64","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.4804","article-title":"Hypocalcemia risk of denosumab across the spectrum of kidney disease: a population-based cohort study","volume":"38","author":"Cowan","year":"2023","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2024.11.013_bib65","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/jbmr.4705","article-title":"Multiple vertebral fractures after denosumab discontinuation: FREEDOM and FREEDOM extension trials additional post hoc analyses","volume":"37","author":"Cosman","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2024.11.013_bib66","article-title":"Interventions for preventing bone disease in kidney transplant recipients","volume":"10","author":"Palmer","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2024.11.013_bib67","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-011-1545-x","article-title":"Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club","volume":"22","author":"Body","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2024.11.013_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ndt\/gfad185","article-title":"Recommended calcium intake in adults and children with chronic kidney disease - a European consensus statement","volume":"39","author":"Evenepoel","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib69","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MCA.0000000000001229","article-title":"Coronary artery calcium progression and all-cause mortality","volume":"34","author":"Eghtedari","year":"2023","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib70","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/cells10051091","article-title":"Vascular calcification progression modulates the risk associated with vascular calcification burden in incident to dialysis patients","volume":"10","author":"Bellasi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.kint.2024.11.013_bib71","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/0886022X.2019.1595646","article-title":"Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"41","author":"Wang","year":"2019","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2024.11.013_bib72","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000294405","article-title":"Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients","volume":"31","author":"Shantouf","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.ajkd.2012.09.007","article-title":"Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study","volume":"61","author":"Takahashi","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib74","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","article-title":"Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients","volume":"27","author":"Braun","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/sdi.12596","article-title":"Imaging for vascular calcification","volume":"30","author":"Raggi","year":"2017","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2024.11.013_bib76","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.ajkd.2012.06.018","article-title":"Associations between coronary calcification on chest radiographs and mortality in hemodialysis patients","volume":"60","author":"Abdelmalek","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib77","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/sj.ki.5001820","article-title":"Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients","volume":"70","author":"Bellasi","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib78","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/toxins14090637","article-title":"Serum calcification propensity represents a good biomarker of vascular calcification: a systematic review","volume":"14","author":"Pluquet","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.kint.2024.11.013_bib79","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.ajkd.2019.01.024","article-title":"Serum calcification propensity and coronary artery calcification among patients with CKD: the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"73","author":"Bundy","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib80","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajt.13443","article-title":"Serum calcification propensity is a strong and independent determinant of cardiac and all-cause mortality in kidney transplant recipients","volume":"16","author":"Dahle","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013060635","article-title":"Serum calcification propensity predicts all-cause mortality in predialysis CKD","volume":"25","author":"Smith","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib82","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/ATVBAHA.120.314187","article-title":"Serum calcification propensity and the risk of cardiovascular and all-cause mortality in the general population","volume":"40","author":"Eelderink","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2024.11.013_bib83","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/j.ajkd.2020.05.031","article-title":"Associations of serum calciprotein particle size and transformation time with arterial calcification, arterial stiffness, and mortality in incident hemodialysis patients","volume":"77","author":"Chen","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib84","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s00467-022-05492-7","article-title":"A\u00a0review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial","volume":"37","author":"Hanudel","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib85","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1681\/ASN.2018101058","article-title":"Effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor-23 in CKD: the COMBINE trial","volume":"30","author":"Ix","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib86","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1681\/ASN.2020040411","article-title":"A\u00a0randomized trial on the effect of phosphate reduction on vascular end points in CKD (IMPROVE-CKD)","volume":"31","author":"Toussaint","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib87","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1681\/ASN.2020050598","article-title":"Optimal phosphate control related to coronary artery calcification in dialysis patients","volume":"32","author":"Isaka","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib88","first-page":"4101","article-title":"Scientific opinion on dietary reference values for calcium","volume":"13","year":"2015","journal-title":"EFSA J"},{"key":"10.1016\/j.kint.2024.11.013_bib89","series-title":"Dietary Reference Intakes for Calcium and Vitamin D","year":"2011"},{"key":"10.1016\/j.kint.2024.11.013_bib90","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib91","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib92","first-page":"1999","article-title":"Dietary intake in adults on hemodialysis compared with guideline recommendations","volume":"34","author":"Saglimbene","year":"2021","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib93","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00467-020-04571-x","article-title":"Dietary calcium intake does not meet the nutritional requirements of children with chronic kidney disease and on dialysis","volume":"35","author":"McAlister","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib94","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2007040449","article-title":"Pitfalls of measuring total blood calcium in patients with CKD","volume":"19","author":"Gauci","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib95","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1210\/jc.2016-1369","article-title":"Hidden hypercalcemia and mortality risk in incident hemodialysis patients","volume":"101","author":"Obi","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2024.11.013_bib96","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1038\/s41598-020-61459-4","article-title":"Hidden hypocalcemia as a risk factor for cardiovascular events and all-cause mortality among patients undergoing incident hemodialysis","volume":"10","author":"Yamaguchi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2024.11.013_bib97","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2215\/CJN.02460310","article-title":"Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients","volume":"5","author":"Evenepoel","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib98","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2215\/CJN.11931116","article-title":"Association of parameters of mineral bone disorder with mortality in patients on hemodialysis according to level of residual kidney function","volume":"12","author":"Wang","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib99","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfz060","article-title":"Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort","volume":"35","author":"Lamina","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10157-022-02288-9","article-title":"Target phosphate and calcium levels in patients undergoing hemodialysis: a post-hoc analysis of the LANDMARK study","volume":"27","author":"Yoshida","year":"2023","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib101","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/ndt\/gfad213","article-title":"Hypocalcemia and cardiovascular mortality in cinacalcet users","volume":"39","author":"Goto","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib102","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2016.19456","article-title":"Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: two randomized clinical trials","volume":"317","author":"Block","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2024.11.013_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213774","article-title":"An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism","volume":"14","author":"Block","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2024.11.013_bib104","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/ndt\/gfz039","article-title":"One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism","volume":"35","author":"Bushinsky","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib105","first-page":"803","article-title":"Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes","volume":"33","author":"Louie","year":"2020","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib106","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/j.ajkd.2021.05.020","article-title":"Etelcalcetide utilization, dosing titration, and chronic kidney disease-mineral and bone disease (CKD-MBD) marker responses in US hemodialysis patients","volume":"79","author":"Karaboyas","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198946","article-title":"A\u00a0prospective study of the influence of the skeleton on calcium mass transfer during hemodialysis","volume":"13","author":"Goldenstein","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2024.11.013_bib108","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1590\/2175-8239-jbn-2020-0098","article-title":"Skeletal and cardiovascular consequences of a positive calcium balance during hemodialysis","volume":"43","author":"Elias","year":"2021","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.kint.2024.11.013_bib109","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(12)80882-1","article-title":"Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate","volume":"18","author":"Hou","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0272-6386(12)70300-1","article-title":"Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol\/L calcium in peritoneal dialysis patients","volume":"20","author":"Bender","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib111","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/ndt\/gfp597","article-title":"Effects of bone remodelling on calcium mass transfer during haemodialysis","volume":"25","author":"Karohl","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib112","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.xkme.2019.08.002","article-title":"Short- and long-term effects of dialysate calcium concentrations on mineral and bone metabolism in hemodialysis patients: the K4 study","volume":"1","author":"Sakoh","year":"2019","journal-title":"Kidney Med"},{"key":"10.1016\/j.kint.2024.11.013_bib113","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1681\/ASN.2015030268","article-title":"Reduction of dialysate calcium level reduces progression of coronary artery calcification and improves low bone turnover in patients on hemodialysis","volume":"27","author":"Ok","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib114","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.kint.2015.12.001","article-title":"Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients","volume":"89","author":"Merle","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/ajkd.1998.v32.pm9669433","article-title":"Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients","volume":"32","author":"van der Sande","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib116","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1053\/j.ajkd.2015.03.038","article-title":"Facility dialysate calcium practices and clinical outcomes among patients receiving hemodialysis: a retrospective observational study","volume":"66","author":"Brunelli","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib117","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.kint.2017.04.019","article-title":"Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference","volume":"92","author":"Baigent","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib118","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2016.05.015","article-title":"Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trials","volume":"68","author":"Palmer","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib119","first-page":"CD006023","article-title":"Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"8","author":"Ruospo","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2024.11.013_bib120","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib121","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.ajkd.2007.12.002","article-title":"A\u00a0comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data","volume":"51","author":"St Peter","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib122","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ekir.2018.03.011","article-title":"Changes with lanthanum carbonate, calcium acetate, and phosphorus restriction in CKD: a randomized controlled trial","volume":"3","author":"Kovesdy","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.11.013_bib123","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00223-017-0347-3","article-title":"Effects of lanthanum carbonate on coronary artery calcification and cardiac abnormalities after initiating hemodialysis","volume":"102","author":"Fujii","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.kint.2024.11.013_bib124","article-title":"Progression of vascular calcification and clinical outcomes in patients receiving maintenance dialysis","volume":"6","author":"Zhang","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.kint.2024.11.013_bib125","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1001\/jama.2021.4807","article-title":"Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing hemodialysis: the LANDMARK randomized clinical trial","volume":"325","author":"Ogata","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2024.11.013_bib126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ndt\/gfv291","article-title":"Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy","volume":"31","author":"Wetmore","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib127","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10157-017-1442-5","article-title":"Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism","volume":"22","author":"Shigematsu","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib128","first-page":"271","article-title":"Safety and efficacy of denosumab in osteoporotic hemodialysed patients","volume":"30","author":"Festuccia","year":"2017","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib130","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1681\/ASN.2020101398","article-title":"A\u00a0randomized trial of tenapanor and phosphate binders as a dual-mechanism treatment for hyperphosphatemia in patients on maintenance dialysis (AMPLIFY)","volume":"32","author":"Pergola","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1681\/ASN.2018080832","article-title":"Efficacy and safety of tenapanor in patients with hyperphosphatemia receiving maintenance hemodialysis: a randomized phase 3 trial","volume":"30","author":"Block","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib132","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.34067\/KID.0002002021","article-title":"Safety and efficacy of tenapanor for long-term serum phosphate control in maintenance dialysis: a 52-week randomized phase 3 trial (PHREEDOM)","volume":"2","author":"Block","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.kint.2024.11.013_bib133","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.ajkd.2023.03.019","article-title":"Tenapanor for the treatment of hyperphosphatemia in Japanese hemodialysis patients: a randomized phase 3 monotherapy study with an up-titration regimen","volume":"82","author":"Fukagawa","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib134","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.ajkd.2023.01.444","article-title":"Patiromer treatment in patients with CKD, hyperkalemia, and hyperphosphatemia: a post hoc analysis of 3 clinical trials","volume":"82","author":"Bushinsky","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.11.013_bib135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11255-020-02387-0","article-title":"Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: review of an alkaline phosphatase-based treatment protocol","volume":"52","author":"Wong","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib136","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/0886022X.2021.2016445","article-title":"A\u00a0single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: a retrospective study","volume":"44","author":"Zhao","year":"2022","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2024.11.013_bib137","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/imj.14209","article-title":"Calcitriol loading before total parathyroidectomy with autotransplant in patients with end-stage kidney disease: does it prevent postoperative hypocalcaemia?","volume":"49","author":"Ferreira","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.kint.2024.11.013_bib138","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1440-1797.2007.00806.x","article-title":"Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome","volume":"12","author":"Davenport","year":"2007","journal-title":"Nephrology"},{"key":"10.1016\/j.kint.2024.11.013_bib139","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jss.2020.05.036","article-title":"A\u00a0nomogram to predict hungry bone syndrome after parathyroidectomy in patients with secondary hyperparathyroidism","volume":"255","author":"Wang","year":"2020","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.kint.2024.11.013_bib140","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/ndt\/gfaa359","article-title":"Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study","volume":"36","author":"Hiramatsu","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib141","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1038\/s41598-022-12029-3","article-title":"Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients","volume":"12","author":"Hori","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2024.11.013_bib142","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ckj\/sfz062","article-title":"Changes in clinical indicators related to the transition from dialysis to kidney transplantation-data from the ERA-EDTA Registry","volume":"13","author":"Tantiyavarong","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2024.11.013_bib143","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ekir.2024.04.004","article-title":"Etelcalcetide use during maintenance hemodialysis and incidence of parathyroidectomy after kidney transplantation","volume":"9","author":"Delaey","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.11.013_bib144","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/ajt.16457","article-title":"Association of time-updated plasma calcium and phosphate with graft and patient outcomes after kidney transplantation","volume":"21","author":"van der Plas","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib145","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1681\/ASN.2021081081","article-title":"Natural history of bone disease following kidney transplantation","volume":"33","author":"J\u00f8rgensen","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib146","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/SLA.0000000000005946","article-title":"Resolution of secondary hyperparathyroidism after kidney transplantation and the effect on graft survival","volume":"278","author":"Wang","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.kint.2024.11.013_bib147","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.surg.2022.07.031","article-title":"Hyperparathyroidism at 1 year after kidney transplantation is associated with graft loss","volume":"173","author":"Crepeau","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.kint.2024.11.013_bib148","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12882-022-02840-5","article-title":"Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia","volume":"23","author":"Okada","year":"2022","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib149","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.surg.2017.12.010","article-title":"Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy","volume":"163","author":"Araujo","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.kint.2024.11.013_bib150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/TP.0000000000000583","article-title":"Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism","volume":"99","author":"Pihlstr\u00f8m","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2024.11.013_bib151","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14085","article-title":"Early persistent hyperparathyroidism post-renal transplantation as a predictor of worse graft function and mortality after transplantation","volume":"34","author":"Isakov","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib152","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ndt\/gfaa210","article-title":"Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA","volume":"36","author":"Bakkaloglu","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib153","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00467-022-05529-x","article-title":"Nutritional management of the infant with chronic kidney disease stages 2-5 and on dialysis","volume":"38","author":"Shaw","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib154","first-page":"47","article-title":"Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA","volume":"35","author":"Bacchetta","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/10408363.2017.1379945","article-title":"The Canadian laboratory initiative on pediatric reference intervals: a CALIPER white paper","volume":"54","author":"Adeli","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.kint.2024.11.013_bib156","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s11255-019-02275-2","article-title":"The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial","volume":"51","author":"Oikonomaki","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib157","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1681\/ASN.2019060579","article-title":"Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: the Valkyrie study","volume":"31","author":"De Vriese","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib158","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/ckj\/sfab017","article-title":"Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial","volume":"14","author":"Levy-Schousboe","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2024.11.013_bib159","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3390\/nu15112422","article-title":"Effect of menaquinone-7 supplementation on arterial stiffness in chronic hemodialysis patients: a multicenter randomized controlled trial","volume":"15","author":"Naiyarakseree","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.kint.2024.11.013_bib160","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ekir.2023.06.011","article-title":"Randomized controlled clinical trial of the effect of treatment with vitamin K2 on vascular calcification in hemodialysis patients (Trevasc-HDK)","volume":"8","author":"Haroon","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2024.11.013_bib161","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ndt\/gfac191","article-title":"Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial","volume":"38","author":"Holden","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib162","first-page":"2300","article-title":"Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial","volume":"15","author":"Saritas","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2024.11.013_bib163","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.119.044195","article-title":"Slowing progression of cardiovascular calcification with SNF472 in patients on hemodialysis: results of a randomized phase 2b study","volume":"141","author":"Raggi","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2024.11.013_bib164","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000488009","article-title":"Effect of sodium thiosulfate on arterial stiffness in end-stage renal disease patients undergoing chronic hemodialysis (Sodium Thiosulfate-Hemodialysis Study): a randomized controlled trial","volume":"139","author":"Saengpanit","year":"2018","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2024.11.013_bib165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ndt\/gfz204","article-title":"Sodium thiosulphate and progression of vascular calcification in end-stage renal disease patients: a double-blind, randomized, placebo-controlled study","volume":"35","author":"Djuric","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib166","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MAT.0000000000001531","article-title":"The effect of sodium thiosulfate on coronary artery calcification in hemodialysis patients","volume":"68","author":"Bian","year":"2022","journal-title":"Asaio J"},{"key":"10.1016\/j.kint.2024.11.013_bib167","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1681\/ASN.2020020225","article-title":"Vitamin K supplementation to improve vascular stiffness in CKD: the K4Kidneys randomized controlled trial","volume":"31","author":"Witham","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib168","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2018111150","article-title":"A\u00a0randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD","volume":"30","author":"Sakaguchi","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib169","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1681\/ASN.0000000000000092","article-title":"The effect of magnesium supplementation on vascular calcification in CKD: a randomized clinical trial (MAGiCAL-CKD)","volume":"34","author":"Bressendorff","year":"2023","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib170","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1111\/ajt.16566","article-title":"The ViKTORIES trial: a randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients","volume":"21","author":"Lees","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib171","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajt.2022.12.015","article-title":"Effect of vitamin K supplementation on serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients: a double-blind, randomized, placebo-controlled clinical trial","volume":"23","author":"Eelderink","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib172","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.kint.2021.10.029","article-title":"Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease","volume":"101","author":"Kaesler","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib173","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/ndt\/gfac171","article-title":"Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients\u2014a systematic review and meta-analysis","volume":"38","author":"Wen","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib174","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/ndt\/gfp755","article-title":"Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients","volume":"25","author":"Adirekkiat","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib175","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.kint.2017.04.011","article-title":"Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats","volume":"92","author":"D\u00edaz","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib176","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/s41598-018-20241-3","article-title":"Magnesium prevents vascular calcification in\u00a0vitro by inhibition of hydroxyapatite crystal formation","volume":"8","author":"Ter Braake","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2024.11.013_bib177","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ndt\/gfaa222","article-title":"Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?","volume":"37","author":"Ter Braake","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib178","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2215\/CJN.16931020","article-title":"Effects of myo-inositol hexaphosphate (SNF472) on bone mineral density in patients receiving hemodialysis: an analysis of the randomized, placebo-controlled CaLIPSO study","volume":"16","author":"Bushinsky","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib179","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ckj\/sfab117","article-title":"The CALCIPHYX study: a randomized, double-blind, placebo-controlled, phase 3 clinical trial of SNF472 for the treatment of calciphylaxis","volume":"15","author":"Sinha","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2024.11.013_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102784","article-title":"Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension","volume":"75","author":"Sinha","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.kint.2024.11.013_bib181","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/gfr658","article-title":"A\u00a0case-control study of calciphylaxis in Japanese end-stage renal disease patients","volume":"27","author":"Hayashi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.11.013_bib182","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.kint.2018.03.016","article-title":"Questionable specificity of histologic findings in calcific uremic arteriolopathy","volume":"94","author":"Ellis","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.11.013_bib183","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/DAD.0000000000001519","article-title":"Calciphylaxis-associated cutaneous vascular calcification in noncalciphylaxis patients","volume":"42","author":"Chaudet","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.kint.2024.11.013_bib184","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cup.13364","article-title":"Factors associated with false-negative pathologic diagnosis of calciphylaxis","volume":"46","author":"Williams","year":"2019","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.kint.2024.11.013_bib185","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2020.05.101","article-title":"The role of skin biopsy in diagnosis and management of calciphylaxis: a retrospective analysis","volume":"85","author":"Dobry","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.kint.2024.11.013_bib186","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000491881","article-title":"The successful use of apixaban in dialysis patients with calciphylaxis who require anticoagulation: a retrospective analysis","volume":"48","author":"Garza-Mayers","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2024.11.013_bib187","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10068","article-title":"Intravenous sodium thiosulphate for calciphylaxis of chronic kidney disease: a systematic review and meta-analysis","volume":"6","author":"Wen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.kint.2024.11.013_bib188","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2256413","article-title":"Multimodality approach to treat calciphylaxis in end-stage kidney disease patients","volume":"45","author":"Lajoie","year":"2023","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2024.11.013_bib189","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jpainsymman.2018.10.514","article-title":"Palliative care use and patterns of end-of-life care in hospitalized patients with calciphylaxis","volume":"57","author":"Olaniran","year":"2019","journal-title":"J\u00a0Pain Symptom Manage"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382400810X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382400810X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T16:05:50Z","timestamp":1750953950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525382400810X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":189,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S008525382400810X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.11.013","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease\u2013mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Kidney Disease: Improving Global Outcomes (KDIGO). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}